Goldman Sachs
ASXC

Goldman Sachs’s Asensus Surgical, Inc. ASXC Stock Holding History

Goldman Sachs’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-7,692
Closed -$170K – 6097
2018
Q1 		$170K Sell
7,692
-19,039
-71% -$436K ﹤0.01% 5070
2017
Q4 		$671K Hold
26,731
– – ﹤0.01% 4597
2017
Q3 		$497K Buy
+26,731
New +$311K ﹤0.01% 5092
2016
Q3 		– Sell
-13,846
Closed -$220K – 7229
2016
Q2 		$220K Sell
13,846
-53,846
-80% -$1.69M ﹤0.01% 5620
2016
Q1 		$3.74M Sell
67,692
-144,708
-68% -$6.2M ﹤0.01% 2936
2015
Q4 		$6.85M Buy
212,400
+69,231
+48% +$2.23M ﹤0.01% 2555
2015
Q3 		$4.21M Buy
+143,169
New +$5.31M ﹤0.01% 3039

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Goldman Sachs's ASXC Position: Q3 2023 in Review

Goldman Sachs sold out of Asensus Surgical, Inc. (ASXC) in Q3 2023, closing a stake of 10,892 shares — an estimated $5.5K sold.

Goldman Sachs first reported a position in ASXC in Q2 2014 and held it in 33 quarters. The position peaked at $3.95M in Q2 2018. 68 funds tracked by Wall St. Rank hold ASXC as of Q3 2023.

  • Goldman Sachs reported no remaining Asensus Surgical, Inc. position as of Q3 2023 after selling out during the quarter.
  • Goldman Sachs sold 10,892 Asensus Surgical, Inc. shares in Q3 2023, an estimated $5.5K.
  • Goldman Sachs first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 33 quarters.
  • Goldman Sachs's Asensus Surgical, Inc. position peaked at $3.95M in Q2 2018.
  • 68 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2023.

Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.